(0.08%) 5 521.25 points
(0.13%) 39 895 points
(0.17%) 19 784 points
(-0.06%) $81.58
(0.68%) $2.83
(-0.26%) $2 338.20
(0.08%) $29.55
(0.43%) $1 006.10
(0.05%) $0.932
(-0.10%) $10.52
(0.01%) $0.788
(-0.81%) $87.28
1.72% $ 109.83
@ $110.53
Wydano: 24 birž. 2024 @ 19:19
Zwrot: -0.63%
Poprzedni sygnał: birž. 21 - 22:01
Poprzedni sygnał:
Zwrot: 3.23 %
Live Chart Being Loaded With Signals
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally...
Stats | |
---|---|
Dzisiejszy wolumen | 808 327 |
Średni wolumen | 767 293 |
Kapitalizacja rynkowa | 6.93B |
EPS | $-0.230 ( Q1 | 2024-05-02 ) |
Następna data zysków | ( $4.71 ) 2024-08-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
22.74 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $4.21 (3.83%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-07 | Carr Patricia | Sell | 163 | Ordinary Shares |
2024-05-03 | Patil Neena M | Sell | 5 000 | Ordinary Shares |
2024-04-05 | Gala Renee D | Sell | 1 736 | Ordinary Shares |
2024-03-06 | Carr Patricia | Sell | 1 236 | Ordinary Shares |
2024-03-06 | Carr Patricia | Sell | 700 | Ordinary Shares |
INSIDER POWER |
---|
42.47 |
Last 96 transactions |
Buy: 315 549 | Sell: 134 118 |
Wolumen Korelacja
Jazz Pharmaceuticals PLC Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
GSHD | 0.928 |
EZGO | 0.867 |
SHLS | 0.866 |
ECPG | 0.863 |
BRZE | 0.861 |
LPRO | 0.855 |
NVEE | 0.855 |
SHCR | 0.853 |
QH | 0.85 |
MODV | 0.848 |
10 Najbardziej negatywne korelacje | |
---|---|
GALT | -0.861 |
GDST | -0.856 |
STOK | -0.848 |
IGLD | -0.844 |
PPTA | -0.84 |
LABP | -0.835 |
XLO | -0.835 |
SBNY | -0.828 |
STAA | -0.828 |
BLIN | -0.824 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Jazz Pharmaceuticals PLC Korelacja - Waluta/Towar
Jazz Pharmaceuticals PLC Finanse
Annual | 2023 |
Przychody: | $3.83B |
Zysk brutto: | $2.79B (72.78 %) |
EPS: | $6.55 |
FY | 2023 |
Przychody: | $3.83B |
Zysk brutto: | $2.79B (72.78 %) |
EPS: | $6.55 |
FY | 2022 |
Przychody: | $3.66B |
Zysk brutto: | $3.12B (85.23 %) |
EPS: | $-3.42 |
FY | 2021 |
Przychody: | $3.09B |
Zysk brutto: | $2.65B (85.76 %) |
EPS: | $-5.52 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Jazz Pharmaceuticals PLC
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement disorders; and in oncology, including hematologic and solid tumors. Its lead marketed products include Xyrem, an oral solution for the treatment of cataplexy and excessive daytime sleepiness (EDS) in narcolepsy patients seven years of age and older; Sunosi for the treatment of EDS in patients with narcolepsy and obstructive sleep apnea; Erwinaze to treat acute lymphoblastic leukemia; Defitelio for the treatment of adult and pediatric patients with hepatic veno-occlusive disease; Vyxeos liposome for injection, a product for the treatment of adults with newly-diagnosed therapy-related acute myeloid leukemia; and Zepzelca for the treatment of adult patients with metastatic small cell lung cancer. The company also offers Xywav, an oxybate product candidate, to treat EDS and cataplexy with narcolepsy and idiopathic hypersomnia; JZP-324, a low sodium oxybate formulation with the potential to provide a clinically meaningful option for narcolepsy patients; JZP385, a T-type calcium channel modulator, for the treatment of essential tremor; JZP458, a recombinant Erwinia asparaginase, for use as a component of a multi-agent chemotherapeutic regimen in the treatment of pediatric and adult patients; and JZP150 for treatment of post-traumatic stress disorder. The company has licensing and collaboration agreements with ImmunoGen, Inc.; Codiak BioSciences, Inc.; Pfenex, Inc.; XL-protein GmbH; and Redx Pharma plc. Jazz Pharmaceuticals plc was incorporated in 2003 and is headquartered in Dublin, Ireland.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej